A Narrative Review of the Coronavirus Disease 2019 Response in the Kingdom of Bahrain

IF 1.6 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Current Therapeutic Research-clinical and Experimental Pub Date : 2024-01-01 DOI:10.1016/j.curtheres.2024.100733
Manaf AlQahtani MD, FRCPC, FRCPI , Jaleela Sayed Jawad MD, MSc , Abdulla AlAwadhi MSc , Basma Mahmood Al Saffar MD, MSc , Ejlal Faisal AlAlawi MD, MSc , Hashim Hadi Sayed Adnan MPH , Hammam Haridy MD , Jean Joury BSPharm, CMD , Graciela del Carmen Morales MD
{"title":"A Narrative Review of the Coronavirus Disease 2019 Response in the Kingdom of Bahrain","authors":"Manaf AlQahtani MD, FRCPC, FRCPI ,&nbsp;Jaleela Sayed Jawad MD, MSc ,&nbsp;Abdulla AlAwadhi MSc ,&nbsp;Basma Mahmood Al Saffar MD, MSc ,&nbsp;Ejlal Faisal AlAlawi MD, MSc ,&nbsp;Hashim Hadi Sayed Adnan MPH ,&nbsp;Hammam Haridy MD ,&nbsp;Jean Joury BSPharm, CMD ,&nbsp;Graciela del Carmen Morales MD","doi":"10.1016/j.curtheres.2024.100733","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><p>The Kingdom of Bahrain has reported more than 696,000 cases of coronavirus disease 2019 (COVID-19) and 1548 associated deaths as of December 26, 2022.</p></div><div><h3>Objectives</h3><p>To better inform responses to future public health threats, this narrative review documents the challenges and responses to the COVID-19 pandemic in the Kingdom of Bahrain.</p></div><div><h3>Methods</h3><p>A PubMed search was conducted focusing on severe acute respiratory syndrome or COVID-19 in Bahrain. Additional relevant references were also included from the authors’ personal reference collections.</p></div><div><h3>Results</h3><p>The search indicated that Bahrain achieved well-established control of the pandemic through robust public health measures, including an early, comprehensive vaccination program. Bahrain was among the first countries to grant emergency authorization for COVID-19 vaccines; as of December 2022, nearly 73% of the eligible population has been fully vaccinated, and approximately 60% has been boosted. Low case rates in recent months highlight Bahrain's successful response to the COVID-19 pandemic.</p></div><div><h3>Conclusions</h3><p>Early organization, robust and systematic protective measures, and a comprehensive vaccination program were key components of the Kingdom's response to the pandemic; traveler quarantines and attempts to combat misinformation were of little or no benefit. These lessons provide guidance for future preparedness to minimize the public health impacts of another pandemic. (<em>Curr Ther Res Clin Exp</em>. 2024; XX:XXX–XXX).</p></div>","PeriodicalId":10920,"journal":{"name":"Current Therapeutic Research-clinical and Experimental","volume":null,"pages":null},"PeriodicalIF":1.6000,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0011393X24000031/pdfft?md5=de87cf74fc105a19560ec04c0c6c322f&pid=1-s2.0-S0011393X24000031-main.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Therapeutic Research-clinical and Experimental","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0011393X24000031","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0

Abstract

Background

The Kingdom of Bahrain has reported more than 696,000 cases of coronavirus disease 2019 (COVID-19) and 1548 associated deaths as of December 26, 2022.

Objectives

To better inform responses to future public health threats, this narrative review documents the challenges and responses to the COVID-19 pandemic in the Kingdom of Bahrain.

Methods

A PubMed search was conducted focusing on severe acute respiratory syndrome or COVID-19 in Bahrain. Additional relevant references were also included from the authors’ personal reference collections.

Results

The search indicated that Bahrain achieved well-established control of the pandemic through robust public health measures, including an early, comprehensive vaccination program. Bahrain was among the first countries to grant emergency authorization for COVID-19 vaccines; as of December 2022, nearly 73% of the eligible population has been fully vaccinated, and approximately 60% has been boosted. Low case rates in recent months highlight Bahrain's successful response to the COVID-19 pandemic.

Conclusions

Early organization, robust and systematic protective measures, and a comprehensive vaccination program were key components of the Kingdom's response to the pandemic; traveler quarantines and attempts to combat misinformation were of little or no benefit. These lessons provide guidance for future preparedness to minimize the public health impacts of another pandemic. (Curr Ther Res Clin Exp. 2024; XX:XXX–XXX).

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
巴林王国 COVID-19 应对措施的叙述性回顾
背景截至 2022 年 12 月 26 日,巴林王国报告的 2019 年冠状病毒病(COVID-19)病例已超过 696,000 例,相关死亡人数为 1548 人。为了更好地应对未来的公共卫生威胁,本综述记录了巴林王国应对 COVID-19 大流行的挑战和措施。检索结果表明,巴林通过采取强有力的公共卫生措施,包括早期的全面疫苗接种计划,有效控制了这一流行病。巴林是首批获得 COVID-19 疫苗紧急授权的国家之一;截至 2022 年 12 月,近 73% 的合格人群已接种了全部疫苗,约 60% 的人群已接种了强化疫苗。最近几个月的低病例率突显了巴林对 COVID-19 大流行的成功应对。结论早期组织、强有力的系统性保护措施以及全面的疫苗接种计划是巴林王国应对大流行的关键组成部分;旅行者隔离和打击误传的尝试几乎没有任何益处。这些经验教训为今后的准备工作提供了指导,以最大限度地减少另一场大流行病对公共卫生的影响。(Curr Ther Res Clin Exp. 2024; XX:XXX-XXX)。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
3.50
自引率
0.00%
发文量
31
审稿时长
3 months
期刊介绍: We also encourage the submission of manuscripts presenting preclinical and very preliminary research that may stimulate further investigation of potentially relevant findings, as well as in-depth review articles on specific therapies or disease states, and applied health delivery or pharmacoeconomics. CTR encourages and supports the submission of manuscripts describing: • Interventions designed to understand or improve human health, disease treatment or disease prevention; • Studies that focus on problems that are uncommon in resource-rich countries; • Research that is "under-published" because of limited access to monetary resources such as English language support and Open Access fees (CTR offers deeply discounted English language editing); • Republication of articles previously published in non-English journals (eg, evidence-based guidelines) which could be useful if translated into English; • Preclinical and clinical product development studies that are not pursued for further investigation based upon early phase results.
期刊最新文献
Inhibitory effects of heat-killed lactic acid bacterium Enterococcus faecalis on the growth of Porphyromonas gingivalis Potentially Inappropriate Medications Use and Associated Factors Among Older Patients on Follow-Up at the Chronic Care Clinic of Hiwot Fana Comprehensive Specialized Hospital in Eastern Ethiopia A Narrative Review of the Coronavirus Disease 2019 Response in the Kingdom of Bahrain Effects of Low-Dose Glucagon on Subcutaneous Insulin Absorption in Pigs Efficacy and Safety of Triple Therapy of Telmisartan/Amlodipine/Rosuvastatin in Patients with Dyslipidemia and Hypertension: A Multicenter Randomized Clinical Trial
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1